BRPI0409484A - interferon beta em sìndrome respiratória aguda severa (sars) - Google Patents

interferon beta em sìndrome respiratória aguda severa (sars)

Info

Publication number
BRPI0409484A
BRPI0409484A BRPI0409484-0A BRPI0409484A BRPI0409484A BR PI0409484 A BRPI0409484 A BR PI0409484A BR PI0409484 A BRPI0409484 A BR PI0409484A BR PI0409484 A BRPI0409484 A BR PI0409484A
Authority
BR
Brazil
Prior art keywords
sars
acute respiratory
respiratory syndrome
severe acute
interferon beta
Prior art date
Application number
BRPI0409484-0A
Other languages
English (en)
Inventor
Giampiero De Luca
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of BRPI0409484A publication Critical patent/BRPI0409484A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"INTERFERON BETA EM SìNDROME RESPIRATóRIA AGUDA SEVERA (SARS)". A presente invenção refere-se ao uso de interferon (IFN) para a fabricação de um medicamento utilizável para o tratamento e/ou prevenção de síndrome respiratória aguda severa (SARS) que é descrito na presente invenção.
BRPI0409484-0A 2003-04-17 2004-04-06 interferon beta em sìndrome respiratória aguda severa (sars) BRPI0409484A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101066 2003-04-17
PCT/EP2004/050456 WO2004091653A1 (en) 2003-04-17 2004-04-06 Interferon beta in severe acute respiratory syndrome (sars)

Publications (1)

Publication Number Publication Date
BRPI0409484A true BRPI0409484A (pt) 2006-05-02

Family

ID=33185950

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409484-0A BRPI0409484A (pt) 2003-04-17 2004-04-06 interferon beta em sìndrome respiratória aguda severa (sars)

Country Status (13)

Country Link
US (1) US20070026014A1 (pt)
EP (1) EP1613342A1 (pt)
JP (1) JP2006523655A (pt)
KR (1) KR20050112127A (pt)
CN (1) CN1798572A (pt)
AU (1) AU2004229185A1 (pt)
BR (1) BRPI0409484A (pt)
CA (1) CA2521650A1 (pt)
EA (1) EA008766B1 (pt)
MX (1) MXPA05011170A (pt)
NO (1) NO20055243L (pt)
UA (1) UA81481C2 (pt)
WO (1) WO2004091653A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110392A2 (en) * 2003-04-01 2004-12-23 Intermune, Inc. Compositions and methods for treating coronavirus infection and sars
US7482149B2 (en) * 2003-06-09 2009-01-27 Genome Institute Of Singapore Inhibition of SARS coronavirus infection with clinically approved antiviral drugs
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders
CA3180390A1 (en) * 2020-03-27 2021-09-30 Fergus MANFORD Compositions for the treatment of a respiratory condition
US20220125661A1 (en) * 2020-10-22 2022-04-28 Jacob Waterman Patient-Worn Therapeutic Apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
KR100694345B1 (ko) * 1998-05-15 2007-03-12 쉐링 코포레이션 리바비린 및 인터페론 알파를 포함하는, 만성 ｃ형 간염에 걸린 항-바이러스 치료에 대한 나이브 환자의 치료용 약제학적 조성물
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
WO2003031587A2 (en) * 2001-10-09 2003-04-17 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Also Published As

Publication number Publication date
EP1613342A1 (en) 2006-01-11
NO20055243L (no) 2005-11-08
US20070026014A1 (en) 2007-02-01
MXPA05011170A (es) 2005-12-14
WO2004091653A1 (en) 2004-10-28
CA2521650A1 (en) 2004-10-28
KR20050112127A (ko) 2005-11-29
AU2004229185A1 (en) 2004-10-28
JP2006523655A (ja) 2006-10-19
EA008766B1 (ru) 2007-08-31
EA200501625A1 (ru) 2006-04-28
UA81481C2 (en) 2008-01-10
CN1798572A (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
BR0314763A (pt) Tratamento de infecções fúngicas
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
BRPI0308663B8 (pt) uso de inibidores de il-18 para o tratamento e/ou prevenção de doenças vasculares periféricas
AR019551A1 (es) Uso de la ribavirina en combinacion con el interferon alfa para la fabricacion de un medicamento para la terapia de combinacion para erradicar hcv-rna detectable en pacientes no afectados a tratamiento antiviral que tienen infeccion de hepatitis c cronica
WO2005020884A3 (en) Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
HUP0301444A2 (hu) Ribavirin és pegilezett alfa-interferon alkalmazása HCV fertőzés kezelésére szolgáló gyógyszerkészítmény előállítására
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BR0209992A (pt) Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BR0316227A (pt) IsÈmeros posicionais de peg ifn alfa 2a
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
HK1128622A1 (en) Use of thymosin
BRPI0409484A (pt) interferon beta em sìndrome respiratória aguda severa (sars)
BRPI0712561B8 (pt) Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO2007057436A3 (en) Interferon in influenza
WO2001076601A3 (en) Pharmaceutical compositions comprising salmeterol and ipratropium
HUP0104126A2 (hu) Gyógyszer a csontmetabolizmus hibáira
WO2002069979A3 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
BR0317947A (pt) Inibidores de quinurenina 3-hidroxilase para o tratamento de diabetes
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
DE60113304D1 (de) Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
BRPI0406673A (pt) Método para o tratamento ou profilaxia e composição para uso no tratamento ou profilaxia de um ou mais sintomas de uma infecção por herpes viral em um indivìduo, e, uso de uma composição compreendendo um sal citrato e/ou um succinato

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.